Aaron Cowen’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$482K Hold
10,800
– – 0.01% 86
2026
Q2
$856K Hold
10,800
– – 0.02% 87
2026
Q1
$811K Hold
10,800
– – 0.02% 80
2025
Q4
$854K Hold
10,800
– – 0.02% 84
2025
Q3
$707K Hold
10,800
– – 0.02% 86
2025
Q2
$427K Hold
10,800
– – 0.01% 91
2025
Q1
$326K Hold
10,800
– – 0.01% 98
2024
Q4
$378K Hold
10,800
– – 0.01% 91
2024
Q3
$433K Hold
10,800
– – 0.01% 93
2024
Q2
$515K Hold
10,800
– – 0.02% 89
2024
Q1
$468K Buy
+10,800
New +$515K 0.02% 96

Other funds holding IONS

Aaron Cowen's IONS Position: Q3 2026 in Review

Aaron Cowen held its Ionis Pharmaceuticals (IONS) position steady in Q3 2026 at 10,800 shares worth $482K. The position accounts for 0.01% of the portfolio, ranked #86.

Aaron Cowen first reported a position in IONS in Q1 2024 and has held it in 11 quarters since. The position peaked at $856K in Q2 2026. 464 funds tracked by Wall St. Rank hold IONS as of Q3 2026.

  • Aaron Cowen held 10,800 shares of Ionis Pharmaceuticals worth $482K as of Q3 2026.
  • Aaron Cowen left its Ionis Pharmaceuticals share count unchanged in Q3 2026.
  • Ionis Pharmaceuticals made up 0.01% of Aaron Cowen's portfolio in Q3 2026, its #86 holding.
  • Aaron Cowen first reported a position in Ionis Pharmaceuticals in Q1 2024 and has held it in 11 quarters since.
  • Aaron Cowen's Ionis Pharmaceuticals position peaked at $856K in Q2 2026.
  • 464 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.

Based on Suvretta Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.